Basic Information
Basic information for OLMALINC-209-12aa
Peptide Name OLMALINC-209-12aa
Genome Position chr10:100388233-100388268[+]
Species Human
Peptide Sequence MYFVHLSQTYKN
Peptide Length 12
Unique No (OLMALINC-205-12aa,OLMALINC-212-12aa,AL359813.1-201-12aa,OLMALINC-215-12aa,OLMALINC-216-12aa,OLMALINC-217-12aa,OLMALINC-218-12aa,OLMALINC-219-12aa,OLMALINC-220-12aa,OLMALINC-221-12aa,OLMALINC-226-12aa,OLMALINC-227-12aa,OLMALINC-228-12aa,OLMALINC-229-12aa)
Grand Average of Hydropathicity -0.4583
Relative Molecular Mass 1728.97
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235823;OLMALINC
Transcript ID/Name ENST00000654563;OLMALINC-209
Transcript Length 1124
Coding Ability 0.5916
DNA Sequence Corresponding to Peptide ATGTACTTTGTACACCTATCCCAAACCTATAAGAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :